Remove Entertainment Remove Public Trading Remove Valuation
article thumbnail

Sports Investment Banking: How to Win the Super Bowl and the World Cup in the Same Year

Mergers and Inquisitions

This sector is the most different in terms of valuation and technical analysis because of nuances around licensing, player salaries, and different revenue streams. Be prepared to discuss a recent sports deal (ideally involving a team or league) and have a rough idea of the trends, drivers, and valuation differences (see below).

article thumbnail

Hopin, the struggling virtual conference unicorn, sells events and engagement units to RingCentral

TechCrunch: M&A

Hopin , the virtual events startup that saw its star (and valuation) rise quickly during the COVID-19 pandemic, is most definitely coming down to earth. Today the company announced that it has sold its Events and Session business units to RingCentral for an undisclosed sum. It will be using the new assets to further diversify its business.

Business 174
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Keeping Up with Delaware Appraisal Jurisprudence Since Aruba: Deal Price Reigns Supreme, But Will Recent Decision Lead to More Arbitrage?

Cooley M&A

However, the Chancery Court’s most recent appraisal decision, In Re Appraisal of Regal Entertainment Group (Del. The Regal appraisal proceeding arose from Cineworld’s acquisition of Regal Entertainment Group in February 2018. Panera Bread was a publicly traded company that JAB Holdings B.V. took private in 2017 for $315/share.

article thumbnail

8 Proven Marketing Strategies for Sustainable Growth

Software Equity Group

Our panel comprises leaders well-versed in go-to-market operations for SaaS businesses of all types, from bootstrapped startups to PE-backed and publicly traded companies. We also put on an annual customer appreciation event, with speakers, tech stations, and entertainment.

Sale 52
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Amid depressed valuations, biotechnology companies also saw an increasing number of demands from activist investors that in certain cases led to more deal activity. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company.

M&A 40